The quest to shorten time to early clinical development

Drug companies looking to increase the efficiency and productivity of their research and development pipelines are turning to a host of techniques and approaches aimed at shortening the time from nonclinical to early clinical development—with promising results—according to a panel of leaders from the research-based drug industry convened by the Tufts Center for the Study of Drug Development (CSDD). Read more here.